| 99190-1 | OASIS E - Special Treatment, Procedures, and Programs - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment | 10 |
| 99191-9 | OASIS E - Medications - DC:-:RptPeriod:^Patient:-:CMS Assessment | 9 |
| 99192-7 | Patient-reported outcomes with LASIK - pre-operative panel:-:Pt:^Patient:-:PROWL | 92 |
| 99283-4 | Tegner activity scale panel:-:Pt:^Patient:-:Tegner | 3 |
| 99287-5 | Checklist of nonverbal pain indicators panel:-:Pt:^Patient:-:CNPI | 5 |
| 99288-3 | Checklist of nonverbal pain indicators with movement panel:-:Pt:^Patient:-:CNPI | 7 |
| 99296-6 | Checklist of nonverbal pain indicators at rest panel:-:Pt:^Patient:-:CNPI | 7 |
| 99306-3 | B-HCG heterph Ab intrf Pnl Ser | 3 |
| 99315-4 | OASIS E - Intervention synopsis - DC, TRN:-:RptPeriod:^Patient:-:CMS Assessment | 30 |
| 99357-6 | COVID-19 health questions panel:-:Pt:^Patient:-: | 23 |
| 99393-1 | Siderocytes Pnl Bld/Mar Prus Bl St | 6 |
| 99417-8 | Shared decision making panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 99548-0 | Gas + Electrolytes Pnl BldA | 9 |
| 99549-8 | Health Leads screening panel:-:Pt:^Patient:-: | 12 |
| 99556-3 | Behavior change panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 99562-1 | Adherence panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 99567-0 | Acceptance of loss panel:-:Pt:^Patient:-:R-Outcomes | 6 |
| 99574-6 | Roland Morris Disability Questionnaire panel:-:Pt:^Patient:-:RMDQ | 3 |
| 99577-9 | Columbia Behavior Scale for Dementia panel:-:Pt:^Patient:-:CBS-8 | 5 |
| 99582-9 | Symptom and timing panel | 2 |
| 99583-7 | Lysholm Knee Scoring Scale:-:Pt:^Patient:-:LKSS | 10 |
| 99593-6 | American Academy of Family Physicians Social Needs Screening Tool:-:Pt:^Patient:-: | 13 |
| 99595-1 | American Academy of Family Physicians Social Needs Screening Tool - short form:-:Pt:^Patient:-: | 9 |
| 99673-6 | COVID-19 Knowledge, Attitudes, and Avoidant Behaviors panel:-:Pt:^Patient:-: | 40 |
| 99674-4 | Temporary pacemaker panel | 23 |
| 99697-5 | Permanent pacemaker panel | 21 |
| 99707-2 | CRRT panel | 34 |
| 99737-9 | Intermittent hemodialysis panel | 36 |
| 99742-9 | Peritoneal dialysis panel | 23 |
| 99745-2 | Patient reported outcomes with LASIK - post-operative panel:-:Pt:^Patient:-:PROWL | 94 |
| 99771-8 | SARS-CoV-2 IGRA Spk+Nuclcp Pnl Bld | 7 |
| 99781-7 | Adalimumab + Adalimumab Ab Pnl SerPl IA | 3 |
| 99788-2 | Functional Communication Measure - Cognition ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS | 6 |
| 99825-2 | Educational impact due to COVID-19 panel:-:Pt:^Patient:-: | 34 |
| 99828-6 | Functional Communication Measure - Multi-Modal Functional Communication panel:-:Pt:^Patient:-:ASHA NOMS | 9 |
| 99836-9 | Functional Communication Measure - Spoken Language Comprehension ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS | 8 |
| 99844-3 | Functional Communication Measure - Spoken Language Expression ages 6 or older panel:-:Pt:^Patient:-:ASHA NOMS | 9 |
| 99852-6 | Functional Communication Measure - Swallowing panel:-:Pt:^Patient:-:ASHA NOMS | 7 |
| 99934-2 | Mainz pain staging system panel:-:Pt:^Patient:-:Mainz Pain Staging System | 17 |
| 99948-2 | Entity Telecom panel | 3 |
| 99952-4 | Entity Address panel | 9 |